PPD announced Tuesday that it has expanded its medical communications services into the Asia-Pacific region. Its new services in the region are managed by teams in Tokyo and Singapore, according to a news release.

The Wilmington-based contract research organization (CRO) has existing communications operations in North America, Latin America and Europe. The Asia-Pacific expansion enables PPD to extend its multi-lingual services to biopharmaceutical clients in all parts of the world, the release stated.

Since its formation in 1991, the PPD medical communications team has managed more than 16 million medical information inquiries, documented more than 3 million adverse events and product complaints, and supported more than 110 product launches, according to the release.

“These efforts are complemented by a full-service, post-approval medical writing team, whose members have prepared more than 8,000 standard responses to address inquiries, as well as numerous dossiers, presentations and manuscripts,” the release continued.

“Expanding our multi-channel medical communications operations into Asia-Pacific strengthens our ability to provide our clients a single source of global medical information services. That ensures consistency of operations around the world while continuing to deliver high-quality health care services and expertise in an efficient, regulatory-compliant and customer-centric manner,” Vivian Broach, vice president of operations and head of PPD’s medical communications operation, said in the release, adding that there is strong demand globally for these services.